Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-05

Clinical Trial Update: Effect of Melatonin on Reduction of Pelvic Pain [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating melatonin for reduction of pelvic pain in dysmenorrhea and endometriosis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Karolinska Institutet | Conditions: Dysmenorrhea, Endometriosis | Phase 2 | Status: COMPLETED